Product Code: ETC13282344 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Acute Bacterial Skin and Skin Structure Infection Market was valued at USD 1.7 Billion in 2024 and is expected to reach USD 3.1 Billion by 2031, growing at a compound annual growth rate of 7.70% during the forecast period (2025-2031).
The Global Acute Bacterial Skin and Skin Structure Infection (ABSSSI) market is experiencing steady growth due to the increasing prevalence of skin infections worldwide. Factors such as rising healthcare expenditure, growing awareness about proper wound care, and the development of novel therapeutics are driving market expansion. Antibiotics remain the primary treatment option for ABSSSI, with key players focusing on developing advanced formulations to combat antibiotic resistance. The market is also witnessing a shift towards outpatient care, leading to the development of more convenient treatment options such as oral antibiotics and outpatient infusion therapy. Additionally, partnerships and collaborations between pharmaceutical companies and research institutions are contributing to the introduction of innovative treatment approaches. The market is expected to continue growing as the demand for effective and efficient solutions for ABSSSI remains high.
The Global Acute Bacterial Skin and Skin Structure Infection Market is experiencing growth due to the increasing prevalence of bacterial infections and the rising demand for effective treatment options. One major trend in the market is the development of novel antibiotics and therapies with enhanced efficacy against resistant strains of bacteria, addressing the growing concern of antibiotic resistance. Additionally, the focus on patient-centric approaches and personalized medicine is creating opportunities for targeted treatments and improved patient outcomes. Market players are also investing in research and development to introduce innovative formulations and delivery methods, such as long-acting injectables and topical treatments, to enhance convenience and compliance. Overall, the market presents opportunities for collaboration between pharmaceutical companies, healthcare providers, and regulatory bodies to drive advancements in treatment options and address unmet medical needs.
The Global Acute Bacterial Skin and Skin Structure Infection (ABSSSI) market faces several challenges, including antibiotic resistance, limited treatment options, and regulatory hurdles. Antibiotic resistance is a significant concern, as bacteria are becoming increasingly resistant to commonly used antibiotics, making treatment less effective and leading to higher healthcare costs. Additionally, the limited availability of novel treatment options for ABSSSI hinders the market`s growth potential. Regulatory challenges, such as stringent approval processes for new drugs, can also slow down innovation in this market. Overall, addressing these challenges requires collaborative efforts among healthcare professionals, pharmaceutical companies, and regulatory bodies to develop effective strategies for combating antibiotic resistance and bringing new treatments to market.
The Global Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Market is primarily driven by the increasing prevalence of skin infections caused by antibiotic-resistant bacteria, such as MRSA. The rise in the number of surgical procedures, diabetic foot ulcers, and other skin-related conditions further fuels the demand for effective treatments. Additionally, the growing awareness about the importance of timely diagnosis and treatment of ABSSSI among healthcare providers and patients is contributing to market growth. The introduction of novel antibiotics, advancements in healthcare infrastructure, and the surge in research and development activities for innovative therapies are also key factors propelling the market forward. Furthermore, strategic collaborations between pharmaceutical companies and healthcare organizations to develop and commercialize new treatment options are expected to drive the market in the coming years.
Government policies related to the Global Acute Bacterial Skin and Skin Structure Infection (ABSSSI) Market focus on promoting the development and approval of innovative antibiotics and treatment options to address the rising prevalence of antibiotic-resistant infections. Regulatory agencies such as the FDA in the United States and the EMA in Europe have implemented expedited review pathways and incentives to accelerate the approval process for new ABSSSI treatments. Additionally, governments have established surveillance programs to monitor antibiotic resistance trends and promote appropriate antibiotic use to combat the emergence of resistant strains. Public health initiatives aim to raise awareness about the importance of proper hygiene practices and vaccination to prevent ABSSSI, while healthcare reimbursement policies incentivize healthcare providers to adopt cost-effective and evidence-based treatment strategies for managing ABSSSI cases.
The Global Acute Bacterial Skin and Skin Structure Infection Market is expected to witness steady growth in the coming years, driven by factors such as the increasing prevalence of bacterial skin infections, rising awareness about proper skin care and hygiene practices, and the introduction of innovative treatment options. The market is also likely to benefit from advancements in medical technology, which could lead to the development of more effective and targeted therapies. Furthermore, the growing geriatric population and the rise in antibiotic-resistant bacterial strains are expected to further fuel market growth. However, regulatory challenges and the high cost of treatment could pose some barriers to market expansion. Overall, the Global Acute Bacterial Skin and Skin Structure Infection Market is projected to experience moderate but consistent growth in the foreseeable future.
In the Global Acute Bacterial Skin and Skin Structure Infection Market, Asia is expected to witness significant growth due to the increasing prevalence of skin infections, rising healthcare expenditure, and improving healthcare infrastructure in countries like China and India. North America is anticipated to dominate the market, driven by the high incidence of bacterial skin infections, advanced healthcare facilities, and presence of key market players. Europe is projected to show steady growth owing to the growing awareness about skin infections and the availability of advanced treatment options. The Middle East and Africa region is likely to experience moderate growth due to improving healthcare access and rising cases of skin infections. Latin America is expected to witness a gradual increase in market growth with improving healthcare facilities and rising healthcare investments in the region.
Global Acute Bacterial Skin and Skin Structure Infection Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Acute Bacterial Skin and Skin Structure Infection Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Global Acute Bacterial Skin and Skin Structure Infection Market - Industry Life Cycle |
3.4 Global Acute Bacterial Skin and Skin Structure Infection Market - Porter's Five Forces |
3.5 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Infection Type, 2021 & 2031F |
3.7 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Acute Bacterial Skin and Skin Structure Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Acute Bacterial Skin and Skin Structure Infection Market Trends |
6 Global Acute Bacterial Skin and Skin Structure Infection Market, 2021 - 2031 |
6.1 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Cellulitis, 2021 - 2031 |
6.1.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Erysipelas, 2021 - 2031 |
6.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Staphylococcus aureus, 2021 - 2031 |
6.2.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Streptococcus pyogenes, 2021 - 2031 |
6.2.4 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pseudomonas aeruginosa, 2021 - 2031 |
6.2.5 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Enterobacteriaceae, 2021 - 2031 |
6.2.6 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Anaerobes, 2021 - 2031 |
6.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Outpatient, 2021 - 2031 |
6.3.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Inpatient, 2021 - 2031 |
6.3.4 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Emergency Departments, 2021 - 2031 |
6.4 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.5 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.4 Global Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
7.1 North America Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
7.2 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.4 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
7.5 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
8.1 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
8.4 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
8.5 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
9.1 Asia Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
9.4 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
9.5 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
10.1 Africa Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
10.4 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
10.5 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
11.1 Europe Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
11.4 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
11.5 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Overview & Analysis |
12.1 Middle East Acute Bacterial Skin and Skin Structure Infection Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
12.4 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Pathogen, 2021 - 2031 |
12.5 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Acute Bacterial Skin and Skin Structure Infection Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Acute Bacterial Skin and Skin Structure Infection Market Key Performance Indicators |
14 Global Acute Bacterial Skin and Skin Structure Infection Market - Export/Import By Countries Assessment |
15 Global Acute Bacterial Skin and Skin Structure Infection Market - Opportunity Assessment |
15.1 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Infection Type, 2021 & 2031F |
15.3 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
15.4 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Acute Bacterial Skin and Skin Structure Infection Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Acute Bacterial Skin and Skin Structure Infection Market - Competitive Landscape |
16.1 Global Acute Bacterial Skin and Skin Structure Infection Market Revenue Share, By Companies, 2024 |
16.2 Global Acute Bacterial Skin and Skin Structure Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |